Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
3
×
life sciences
national blog main
san francisco blog main
san francisco top stories
boston blog main
cancer
clinical trials
fda
national top stories
new york blog main
novartis
raleigh-durham blog main
san diego blog main
seattle blog main
seattle top stories
takeda pharmaceutical
venture capital
10x genomics
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astellas pharma
astrazeneca
becton dickinson
biofourmis
biogen
biovotion
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
What
help
3
×
deal
acquisitions
adding
aims
analytics
announced
bio
biofourmis
ceo
collabs
company
covid
daniel
data
decisions
devices
diagnostic
diagnostics
digital
employs
expand
fold
gilead
gilead’s
globally
hauls
introduce
ipo
make
medicines
million
month
nanostring
o’day
patients
physicians
plans
raised
reach
Language
unset
3
×
Current search:
deals
×
help
×
unset
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
